panobinostat
Generic: PANOBINOSTAT LACTATE·Brand: FARYDAK, Farydak
panobinostat: 1 clinical trial tracked.
panobinostat evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about panobinostat, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence3 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Clinical Trial Registry Records (1)
Open Label, Multi-center, Phase IV Study of Ruxolitinib or Ruxolitinib and Panobinostat Combination, for Patients Who Have Completed Prior Global Novartis or Incyte Sponsored Studies
Primary endpoint: Incidence and severity of AEs and SAEs
Interventionalopen279 enrolledStarted 2015-03Completion 2032-0450 sites · Australia, Belgium, Bulgaria, Canada…Novartis Pharmaceuticals